Virios Therapeutics, Inc.
A biotechnology company developing treatments for diseases caused by abnormal immune responses to viruses. The company is developing IMC-1, a novel treatment that suppresses the activation and replication of HSV-1, a virus believed to be the cause of chronic diseases such as fibromyalgia, irritable bowel disease, and chronic fatigue syndrome, by combining a unique mechanism of action that puts the virus into a dormant or latent state. The company is based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Georgia |
Employees | 4 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 6.94M |
Revenue | |
Operating Income | -5.20M |
Operating Margin | |
Net Income | -5.07M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3354 / 5373 |
Sector : Healthcare | 262 / 1144 |
Industry : Biotechnology | 57 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 5296 / 5565 |
Sector : Healthcare | 1060 / 1182 |
Industry : Biotechnology | 596 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3206 / 5436 |
Sector : Healthcare | 253 / 1164 |
Industry : Biotechnology | 67 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 5157 / 5330 |
Sector : Healthcare | 1128 / 1174 |
Industry : Biotechnology | 629 / 667 |